Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongying Tiandong Pharmaceutical Co., Ltd.
Dongying, Shandong, Chinatd-pharm.com ↗
- Ownership
- Private
- Employees
- ~375
- Development stage
- Other
01
Overview
The company manufactures commercial-scale polysaccharide APIs including enoxaparin sodium, heparin sodium/calcium, nadroparin calcium, dalteparin sodium. It also has a clinical-stage program with batroxobin injection currently in Phase I trials in China. The company has previously faced regulatory scrutiny but remains active and supplies globally.[1][2][3][5]
- Therapeutic areas
- CardiovascularHematology
- Modalities
- Small molecules (polysaccharide-based drugs such as heparins and low molecular weight heparins)[1][4][6]Enzyme biologics (e.g., batroxobin)[3]
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Dongying Tiandong Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dongying Tiandong Pharmaceutical Co., Ltd..